Quality of life in patients with pancreatic cancer

Valerie Lee, Haiying Cheng, Guangyuan Li, Muhammad Wasif Saif

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Pancreatic cancer is a rapidly fatal disease with palliation often serving as the main goal of treatment. The end of life is often marked by severe symptoms and poor quality of life (QoL). Several studies presented at the 2012 ASCO Gastrointestinal Cancers Symposium addressed the importance of symptom identification and management for patients with pancreatic cancer: 1) a study evaluating the correlation between patient-reported symptoms, disease burden and treatment duration in patients with advanced pancreatic cancer undergoing gemcitabine-based chemotherapy (Abstract #370); 2) a Japanese study found that patients without worsening of pain or sleep symptoms at one month of chemotherapy had higher frequency of disease control (Abstract #195); and 3) a study showed that fear of cancer recurrence is a substantial problem following resection and should be targeted (Abstract #289). The authors summarize the findings and discuss the importance of QoL in these patients. The results of these studies may facilitate in identifying symptom changes as predictive markers, and improving care and QoL for patients with this devastating disease.

Original languageEnglish (US)
Pages (from-to)182-184
Number of pages3
JournalJournal of the Pancreas
Volume13
Issue number2
StatePublished - 2012
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Quality of Life
gemcitabine
Drug Therapy
Gastrointestinal Neoplasms
Fear
Sleep
Recurrence
Pain
Therapeutics
Neoplasms

Keywords

  • Palliative care
  • Pancreatic neoplasms
  • Quality of life

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Hepatology

Cite this

Lee, V., Cheng, H., Li, G., & Saif, M. W. (2012). Quality of life in patients with pancreatic cancer. Journal of the Pancreas, 13(2), 182-184.

Quality of life in patients with pancreatic cancer. / Lee, Valerie; Cheng, Haiying; Li, Guangyuan; Saif, Muhammad Wasif.

In: Journal of the Pancreas, Vol. 13, No. 2, 2012, p. 182-184.

Research output: Contribution to journalArticle

Lee, V, Cheng, H, Li, G & Saif, MW 2012, 'Quality of life in patients with pancreatic cancer', Journal of the Pancreas, vol. 13, no. 2, pp. 182-184.
Lee, Valerie ; Cheng, Haiying ; Li, Guangyuan ; Saif, Muhammad Wasif. / Quality of life in patients with pancreatic cancer. In: Journal of the Pancreas. 2012 ; Vol. 13, No. 2. pp. 182-184.
@article{e3ae443ec6e448ec8f3b7136fbadc082,
title = "Quality of life in patients with pancreatic cancer",
abstract = "Pancreatic cancer is a rapidly fatal disease with palliation often serving as the main goal of treatment. The end of life is often marked by severe symptoms and poor quality of life (QoL). Several studies presented at the 2012 ASCO Gastrointestinal Cancers Symposium addressed the importance of symptom identification and management for patients with pancreatic cancer: 1) a study evaluating the correlation between patient-reported symptoms, disease burden and treatment duration in patients with advanced pancreatic cancer undergoing gemcitabine-based chemotherapy (Abstract #370); 2) a Japanese study found that patients without worsening of pain or sleep symptoms at one month of chemotherapy had higher frequency of disease control (Abstract #195); and 3) a study showed that fear of cancer recurrence is a substantial problem following resection and should be targeted (Abstract #289). The authors summarize the findings and discuss the importance of QoL in these patients. The results of these studies may facilitate in identifying symptom changes as predictive markers, and improving care and QoL for patients with this devastating disease.",
keywords = "Palliative care, Pancreatic neoplasms, Quality of life",
author = "Valerie Lee and Haiying Cheng and Guangyuan Li and Saif, {Muhammad Wasif}",
year = "2012",
language = "English (US)",
volume = "13",
pages = "182--184",
journal = "Journal of the Pancreas",
issn = "1590-8577",
publisher = "E.S. Burioni Ricerche Bibliografiche",
number = "2",

}

TY - JOUR

T1 - Quality of life in patients with pancreatic cancer

AU - Lee, Valerie

AU - Cheng, Haiying

AU - Li, Guangyuan

AU - Saif, Muhammad Wasif

PY - 2012

Y1 - 2012

N2 - Pancreatic cancer is a rapidly fatal disease with palliation often serving as the main goal of treatment. The end of life is often marked by severe symptoms and poor quality of life (QoL). Several studies presented at the 2012 ASCO Gastrointestinal Cancers Symposium addressed the importance of symptom identification and management for patients with pancreatic cancer: 1) a study evaluating the correlation between patient-reported symptoms, disease burden and treatment duration in patients with advanced pancreatic cancer undergoing gemcitabine-based chemotherapy (Abstract #370); 2) a Japanese study found that patients without worsening of pain or sleep symptoms at one month of chemotherapy had higher frequency of disease control (Abstract #195); and 3) a study showed that fear of cancer recurrence is a substantial problem following resection and should be targeted (Abstract #289). The authors summarize the findings and discuss the importance of QoL in these patients. The results of these studies may facilitate in identifying symptom changes as predictive markers, and improving care and QoL for patients with this devastating disease.

AB - Pancreatic cancer is a rapidly fatal disease with palliation often serving as the main goal of treatment. The end of life is often marked by severe symptoms and poor quality of life (QoL). Several studies presented at the 2012 ASCO Gastrointestinal Cancers Symposium addressed the importance of symptom identification and management for patients with pancreatic cancer: 1) a study evaluating the correlation between patient-reported symptoms, disease burden and treatment duration in patients with advanced pancreatic cancer undergoing gemcitabine-based chemotherapy (Abstract #370); 2) a Japanese study found that patients without worsening of pain or sleep symptoms at one month of chemotherapy had higher frequency of disease control (Abstract #195); and 3) a study showed that fear of cancer recurrence is a substantial problem following resection and should be targeted (Abstract #289). The authors summarize the findings and discuss the importance of QoL in these patients. The results of these studies may facilitate in identifying symptom changes as predictive markers, and improving care and QoL for patients with this devastating disease.

KW - Palliative care

KW - Pancreatic neoplasms

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84863350416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863350416&partnerID=8YFLogxK

M3 - Article

C2 - 22406597

AN - SCOPUS:84863350416

VL - 13

SP - 182

EP - 184

JO - Journal of the Pancreas

JF - Journal of the Pancreas

SN - 1590-8577

IS - 2

ER -